Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00612963 · ClinicalTrials.gov registry record
Novel Rinse to Treat in Oral Candidiasis in Cancer Patients
A clinical trial, sponsored by Biomedical Development Corporation.
- Completed
- Registry status
- 23
- Enrollment target
NCT00612963 is a clinical trial that has completed, run by Biomedical Development Corporation. The registered enrollment target is 23 participants.
The verdict
NCT00612963 has completed, sponsored by Biomedical Development Corporation.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the efficacy of Iocide oral rinse as a treatment for Oral Candidiasis in any patient including but not limited to patients receiving radiation therapy or who have previously received radiation therapy for head and neck cancer, or patients positive for HIV/AIDS or are transplant patients.
Interventions
- DRUG Frio Oral Rinse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00612963
The ClinicalTrials.gov registry entry for NCT00612963 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biomedical Development Corporation, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Frio Oral Rinse is the first listed.
NCT00612963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00612963 about?
NCT00612963 is a clinical study titled "Novel Rinse to Treat in Oral Candidiasis in Cancer Patients". The purpose of the study is to evaluate the efficacy of Iocide oral rinse as a treatment for Oral Candidiasis in any patient including but not limited to patients receiving radiation therapy or who have previously received radiation therapy for head and neck cancer, or patients positive for HIV/AIDS...
What is the current status of trial NCT00612963?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2007-04. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00612963?
The interventions under investigation include: Frio Oral Rinse (DRUG).
Who is sponsoring clinical trial NCT00612963?
This trial is sponsored by Biomedical Development Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.